MLchartDataset catalogue

autologous anti-CD19 CAR-expressing T lymphocytes CLIC-1901

Term · Oncology and biomedicine · MLC-T-ONC-011365

A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) that targets the human tumor associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD19 CAR-expressing T lymphocytes CLIC-1901 bind to and induce selective toxicity against CD19-expressing tumor cells. The CD19 antigen is a B-cell-specific cell surface antigen expressed in all B-cell lineage malignancies.

Table 1. Record
IdentifierMLC-T-ONC-011365
FieldOncology and biomedicine
Synonymsautologous CLIC-1901 CAR-T cells
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011365",
  "term": "autologous anti-CD19 CAR-expressing T lymphocytes CLIC-1901",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes that have been genetically modified to express a chimeric antigen receptor (CAR) that targets the human tumor associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon administration, autologous anti-CD19 CAR-expressing T lymphocytes CLIC-1901 bind to and induce selective toxicity against CD19-expressing tumor cells. The CD19 antigen is a B-cell-specific cell surface antigen expressed in all B-cell lineage malignancies.",
  "synonyms": [
    "autologous CLIC-1901 CAR-T cells"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-anti-cd19-car-expressing-t-lymphocytes-clic-1901/"
}

Record 2,697 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.